We conducted the largest study of snoring using data from the UK Biobank (n ~ 408,000; snorers ~152,000). A genome-wide association study (GWAS) identified 42 genome-wide significant loci, with a SNP-based heritability estimate of ~10% on the liability scale. Genetic correlations with body mass index, alcohol intake, smoking, schizophrenia, anorexia nervosa and neuroticism were observed. Gene-based associations identified 173 genes, including DLEU7, MSRB3 and POC5 highlighting genes expressed in brain, cerebellum, lungs, blood, and oesophagus tissues. We used polygenic scores (PGS) to predict recent snoring and probable obstructive sleep apnoea (OSA) in an independent Australian sample (n~8,000). Mendelian randomisation analyses provided evidence that larger whole body fat mass causes snoring. Altogether, our results uncover new insights into the aetiology of snoring as a complex sleep-related trait and its role in health and disease beyond being a cardinal symptom of OSA.
INTRODUCTION
Snoring is the vibration of upper airway structures that occurs when the muscles of the airway relax during sleep, thus creating noise as the air passes in and out while breathing. Habitual snoring is common in the population, its overall prevalence increases with age and is higher in males (35-45%) than females (15-28%). 1 Importantly, snoring is a hallmark of OSA, a sleep-related breathing disorder characterised by repeated episodes of complete or partial obstructions of the upper airway during sleep, despite the effort to breathe. 1 OSA is usually associated with a reduction in blood oxygen saturation, and is often accompanied by associated daytime symptoms, such as excessive daytime sleepiness, fatigue and decreased cognitive function. While the vast majority of patients with OSA exhibit snoring, a minority (20-25%) of patients with central sleep apnoea do not snore, 2 and it is estimated that sleep apnoea may occur in as many as 20 to 40 percent of the adult population that are snorers, leaving the remaining 60-80% of snorers in the category of habitual non-apnoeic benign snorers. Snoring has previously been associated with body mass index (BMI) 3, 4 as well as with risk of cardiovascular disease, such as coronary heart disease and stroke among postmenopausal women. 5 Twin and family studies have demonstrated the existence of a genetic predisposition to habitual snoring, with heritability estimates suggesting that 18-28% of variance can be accounted for by genetic factors 4, 6 . A proportion of its heritability may be mediated through other heritable lifestyle factors such as smoking and alcohol consumption which can also contribute to snoring. [7] [8] [9] Snoring is known to reduce sleep quality for both snorers and their sleeping partners, 10, 11 reducing energy/vitality and increasing daytime anxiety, 12 risk of depression, stress, fatigue and sleepiness. 11 Here, we leverage data from the UK Biobank and an Australian sample of adults, in an effort to characterise the molecular underpinnings of habitual snoring as a complex, polygenic trait, and investigate its relationship to known correlates such as BMI, smoking and alcohol consumption. We also employ statistical genetics methods such as LD score regression and Mendelian randomisation to identify genetically correlated traits with snoring and assess causality. Furthermore, we used our GWAS results to estimate individual PGS and predict snoring and probable OSA in an independent sample of Australian adults.
RESULTS
Snoring prevalence and risk factors. Our population-based discovery sample consisted of 408,317 individuals of white British ancestry from the UK Biobank. Participants in the sample were deemed as snoring 'cases' (37%) based on their report that a partner or housemate had complained to the participant about their snoring (see Methods and Table 1 ). Snoring was significantly associated with age (OR=1.011 [per year, 95% CI 1.009-1.012]) and, to a greater extent, with sex (ORmales=2.264 [2.212-2.316] ). The prevalence of sleep apnoea was higher within the snorer group (Table 1) . Furthermore, BMI, smoking frequency and alcohol consumption frequency were also associated with snoring ( Figure 1a ). While snoring prevalence was higher in males, BMI was positively correlated with snoring prevalence in both males and females ( Figure 1b ). Smoking frequency was positively correlated with snoring prevalence in females, and to a lesser extent in males (Figures 1a and 1c ). In contrast, alcohol consumption frequency was correlated with snoring in males, and to a lesser extent in females (Figures 1a and 1d ). We further identified other factors such as whole body fat mass and sleep duration that are correlated with snoring ( Supplementary Table 1 ).
Discovery GWAS and SNP heritability.
We performed a GWAS of snoring, taken as a dichotomous variable (n = 408,317; cases~152,000; controls~256,000). After quality control (see Methods), 11,010,159 genetic variants remained in the analysis. This uncovered 127 independent genome-wide significant associations across 41 genomic risk loci (Figure 2 and Supplementary   Figure 1 ). 13 Annotation for the top 15 risk loci is shown in Table 2 , and a list of all genomic risk loci is given in Supplementary File Overall, traits related to body-mass index, risk for psychiatric disease, lung function and heart disease were among those with the strongest evidence of association ( Figure 3 and Supplementary File 2).
Notably, pulse rate, whole body fat mass and BMI were also phenotypically associated with snoring in this sample (see above and Supplementary Table 1 ).
Sensitivity Analysis.
We performed a follow-up sensitivity GWAS for snoring including BMI as a covariate to explore the effects of BMI on associated variants. The results revealed 97 genome-wide significant SNPs across 34 genomic risk loci ( Figure 2 ) with overall SNP heritability on the liability 16 , RNA5SP471 16, 17 and SND1 and NSUN3, previously associated with alcohol consumption; 14, [16] [17] [18] FTO and SND1, associated with coffee consumption; 19 LMO4 associated with insomnia; 20 and RNA5SP471 with narcolepsy. 20, 21 Also, ROBO2, previously associated with chronotype; 22, 23 and multiple genes (DLEU7, MSRB3, FTO, ANAPC4, SMG6, SND1, SIM1, KCNQ5, CEP120, MACF1, SNAP91 and BCL2) previously associated with musculoskeletal traits such as height and heel bone mineral density (Supplementary File 1 and Supplementary File 2). [24] [25] [26] [27] Genome-wide gene-based association analysis identified 179 genes associated with snoring beyond genome wide significance (p<2.636e-6; bonferroni corrected threshold for 18,971 tested genes) several of which were consistent with the mapped genes. After adjusting for BMI, 104 protein coding genes were identified mapping to a genome-wide significant SNP from the positional and eQTL mapping while 120 genes remained significantly associated with snoring, including both MSRB3 and DLEU7 (See Supplementary Figure 2 and Supplementary Files 2 and 3 ). eQTL data obtained from GTEx and mapped with FUMA highlighted significant SNPs that were associated with the expression of genes in several tissues including lungs, blood, oesophagus, breast mammary, tibial nerve, and several areas of the brain, such as the cerebellum and hippocampus ( Supplementary Figure 3 and Supplementary File 2). In summary, many of the mapped genes for snoring have been previously associated with other traits and diseases, primarily grouped into cardiometabolic, cognitive/neurological, respiratory and psychiatric ( Figure 4 and Supplementary File 1).
To further assess whether significant genes converged in functional gene sets and pathways, we conducted gene-set enrichment analyses of tissue expression data ( Supplementary Figure 3a) . Genes expressed in blood vessel and tibial artery tissue were associated with snoring, even after adjusting for BMI ( Supplementary Figure 3b ). Given these associations, and an observed genetic correlation between snoring and pulse rate (rG= 0.106, S.E.= 0.03, p-value=0.001), we conducted two sample Generalised Summary-data-based Mendelian Randomisation (GSMR) 28 to test for a possible causal relationship. The analysis suggested a one-way causal relationship in which snoring increased pulse rate ( Supplementary Figure 4) . We further explored the association between snoring and BMI or whole body fat mass. GSMR results suggested a bidirectional causal relationship, with snoring exerting a causal effect on BMI, but also BMI exerting a causal effect on snoring. However, a oneway causal relationship was seen for whole body fat mass causing snoring (Supplementary Figure   4 ). To control for possible confounding due to sample overlap, we repeated the Mendelian randomisation analyses using sex-stratified GWAS results (see Methods). This confirmed the causal associations between BMI or whole body fat mass causing snoring, while all other associations did not retain statistical significance after controlling for multiple testing ( Figure 5 and Supplementary   Table 2 ).
Sex-stratified GWAS. Given the higher prevalence of snoring in males, we conducted GWAS analyses stratified by sex. These analyses identified 4 and 25 genome-wide significant SNPs for snoring in males and females, respectively. SNP heritability on the liability scale (h 2 SNP) was 8.77%
(S.E.=0.54%) and 12.42% (S.E.=0.57%) respectively for males and females (Table 3 ). In the sensitivity analyses, SNP heritability (h 2 SNP) was slightly lower after adjusting for BMI in both males 7.72% (S.E.=0.56%) and females 10.85% (S.E.=0.54%) ( Figure 5 ).
Polygenic scores and prediction on an independent target sample.
We used the discovery GWAS summary statistics to derive PGS in an independent target sample from the Australian Genetics of Depression Study (AGDS). The prevalence of self-reported recent snoring was 32%, with a higher 9 prevalence in males than females (43.2% and 28.1% respectively). PGS for snoring were significantly associated with recent snoring for all but one (p<=5e-8) of the p-value inclusion thresholds ( Figure   6 and Supplementary Figure 6 ). Participants in the highest snoring PGS decile had around twice the odds of reporting recent snoring and choking or struggling for breath during sleep (i.e. probable OSA; sample prevalence=8.2%) compared to those on the lowest decile ( Figure 6a ). Furthermore, the PGS showed a stronger association with increasing frequency of snoring severity (Figure 6b ). Finally, we showed that the snoring PGS explained a significant amount of variance in recent snoring ( Figure   6c ).
DISCUSSION
This study advances our understanding of the aetiology and genetic architecture of snoring. Overall, snoring prevalence was higher in males than in females, having a strong and positive correlation with BMI, tobacco smoking and alcohol consumption in both sexes. The effects of BMI, smoking and alcohol consumption have been previously reported in other studies. 7, 29, 30 In our study, tobacco smoking displayed a stronger association with snoring in females compared to males, a result consistent with an observations in an independent sample of ~15,000 Europeans published in 2004. 30 Previous studies provided evidence that women might have a greater susceptibility to chronic obstructive pulmonary disease after smoking 31 and a greater bronchial hyperresponsiveness after methacholine challenge. 32 These results suggest that smoking might be associated with snoring through an increased inflammatory response and irritation of the airways, thus having a larger effect size on females, compared to males. Conversely, our study indicates that the frequency of alcohol consumption has a stronger influence on snoring in males, compared to females. This is consistent with a previous study which failed to identify an association between alcohol consumption and snoring in females but did so in males. 33 Our results strengthen the evidence pointing to alcohol as a risk factor for snoring and sleep apnoea, potentially through a weakening (relaxation) effect in the jaw and pharyngeal muscles. 34 Future studies should leverage statistical genetics methods such as polygenic scoring or Mendelian randomisation to further characterise the role of smoking and alcohol-related phenotypes in snoring.
The sex differences described above motivated us to perform sex-stratified GWAS. The larger sample size of the female subgroup conferred more power to detect genetic associations in our analyses. The observed high cross-sex genetic correlation, and a high concordance in effect size and direction amongst the top hits suggests that differences in sex-stratified GWAS might be simply due to power differences between the male and female subsamples rather than the existence of sex-specific genetic effects.
Top genes identified from gene-based test analysis for snoring included DLEU7 and MSRB3.
Previous reports have associated DLEU7 with heel bone mineral density, 24, 35 BMI, 36, 37 height, 38, 39 cardiovascular diseases, 40 systolic blood pressure 40 and pulmonary function decline (forced expiratory volume). 41 The association between snoring genes and heel bone mineral density could be mediated by BMI due to the association between BMI and bone density documented previously. 42 MSRB3 plays a relevant role in protein and lipid metabolism pathways 43 and has been associated with hippocampal volume, [44] [45] [46] lung function, 40, 47, 48 Alzheimer's disease, 49 ,50 brain injuries, 51 novelty seeking, 52 deafness 53 and height. 40 These results could be consistent with the fact that severe snoring may incur in nocturnal oxygen desaturation, 54 diminishing neuropsychological functions and in some cases, resulting in tissue damage 55 and contributing to impairment of memory consolidation processes. 56 However, more research is needed in order to test this hypothesis.
Genetic correlations between snoring and a variety of traits and diseases were identified. The trait with the highest genetic correlation with snoring is sleep apnoea, which is consistent with loud snoring being a diagnostic criterion for OSA. This observation is also remarkable given the small sample size (less than 2000 cases) and therefore reduced power (no genome-wide hits) that the GWAS for self-reported sleep apnoea has in the UK Biobank. Our analyses suggest that a GWAS for snoring captures a substantial portion of the genetic contribution to sleep apnoea, highlighting the importance of studying symptoms on a subclinical threshold, an approach that has already proven useful at understanding the heterogeneity of other complex traits such as depression and neuroticism. 57, 58 Our study will enable future efforts aimed at understanding the underlying genetic architecture of OSA using multivariate statistical genetic approaches.
We also observed moderate correlations with BMI, obesity and whole body fat mass. Other relevant correlations included lung function, neurological, cardiovascular and psychiatric diseases. The high genetic correlation between snoring and snoring adj. BMI (rG=0.923, S.E.=0.003, p-value=1x10 -300 ) supports the idea that the genetic architecture of snoring cannot be explained simply by BMI. This highlights the importance of studying snoring as a trait in its own, which might open new opportunities to the understanding of highly related sleeping disorders, including OSA, as well as its relationship with other traits and diseases.
Our initial Mendelian randomisation results suggested a mutual causal relationship between BMI and snoring, but only a one-way causal relationship of whole body fat mass causing snoring. We hypothesise BMI to be more heterogeneous and potentially more pleiotropic than whole body fat mass. In fact Mendelian randomisation is known to be confounded by pleiotropy. 59 Interestingly, a one-way causal relationship between snoring and pulse rate, which survived adjustment for BMI, was identified. Nonetheless, this association did not reach statistical significance when accounting for sample overlap (i.e. sex-stratified GSMR). The only causal associations that survived this were BMI or whole body fat mass causing snoring. The significantly lower number of instruments available for snoring as an exposure (Supplementary Table 2 ) makes it hard to assess whether the results were due to a lack of power or a lack of true causal effect. Future efforts could leverage novel statistical genetics methods that use all the GWAS results to test whether the associations observed could be explained by a causality rather than pleiotropy. 60 Finally, we assessed the validity of our GWAS results by using genetic scoring on an independent sample of Australian adults with data on recent snoring. Our successful prediction of snoring using PGS supports the external validity of our genetic association results. Remarkably, we predicted probable OSA using a snoring derived PGS. Thus, investigating the aetiology of snoring could also help uncover the aetiology and genetic architecture of OSA, a task that has proved difficult and challenging 61 . Future efforts could assess whether the utility of snoring derived PGS as an addition to the current battery of tests used to more accurately diagnose OSA, 62 particularly given the issue of potential OSA underdiagnosis. 63, 64 Our results highlight the relevance of studying snoring as an independent trait, and provide important insights into its aetiology and genetic architecture. This study represents the largest genetic investigation of snoring to date. However, some limitations must be acknowledged. Analyses used self-reported snoring with the item relying on a partner or close friend complaining about the participant's snoring. Thus, the case definition might be subject to participant specific recall and subjective biases. Nonetheless, we hypothesize that this limitation might result in the inclusion of some cases as controls (i.e. snoring participants living alone) and therefore bias our results toward the null rather than creating false positives. To avoid confounding due to population stratification, we only included samples of European ancestry in our analyses. This is particularly important given reports of ethnic differences associated with snoring prevalences. 65 Nonetheless, excluding other populations can limit the generalisability of these results outside the populations studied. As previously discussed, we cannot identify which, if any, sex-specific genetic observations (e.g.
differences in SNP heritability) are due to true genetic effects rather than power differences between the samples. Finally, the fact that PGS for snoring predicted less than one percent of the variance on recent snoring suggest that the GWAS is still underpowered 66 . The heritability for snoring in twin studies is estimated in the range of 18 to 28% 6 , although some of the missing heritability for snoring may come from dominant genetic effects, it is likely that an increased power and studying rare variants 67 yields more powered genetic predictors.
In summary, we provide insights into the aetiology of snoring, its risk factors and genetic underpinnings. Our observational analyses showed a higher prevalence of snoring in males compared to females, and effects of age, BMI, smoking and alcohol consumption. In addition, tobacco smoking showed a higher effect on snoring prevalence in females compared to males while alcohol consumption displayed a higher effect on snoring prevalence in males compared to females. GWAS identified 127 genome-wide significant associations across 41 genomic risk loci with h 2 SNP = 9.9%.
We found no evidence for sex-specific genetic factors, and showed that most of the SNP heritability identified is not simply due to BMI. We also found evidence of a causal relationship from BMI or whole body fat mass to snoring. We further found evidence of genetic overlap between snoring and other cardiometabolic, respiratory, neurological and psychiatric traits. Finally, we used the GWAS summary statistics to derive individual PGS and predict both recent snoring and probable OSA in an independent sample of Australian adults, thus confirming the relevance of snoring as a sleep-related complex trait. Future studies should aim at leveraging powered GWAS on alcohol and tobacco behaviours to assess whether they are truly causal of snoring, and to assess the amount of shared genetic overlap between OSA and habitual snoring, as the latter may serve to boost the power of obstructive sleep apnoea genetic studies.
Discovery sample and phenotypic information.
Participants included in the present study were of European ancestry from the UK Biobank. Briefly, this resource recruited participants between 2006 and 2010 to assess lifestyle, anthropometric and health related variables. Participants self-reported on sleep-related traits. Snoring was assessed as a single item (Field-ID: 1210): "Does your partner or a close relative or friend complain about your snoring?" This question could be answered with "Yes", "No", "Don't know", or "Prefer not to answer". We excluded participants whose answers were "Don't know" (n = 29,309) or "Prefer not to answer" (n = 6,854) from our analyses. (Supplementary Table 3 shows the total sample size for each GWAS, including sensitivity and sex-stratified analyses). OSA cases were determined on the basis of either ICD-10 diagnosis code or self-report of sleep apnoea diagnosis in the UK Biobank.
Data extraction and statistical analyses
Raw data was extracted from the UK Biobank under Application Number 25331. For a description of the field codes and instances used refer to Supplementary Table 4 . Data was re-coded to remove missing data and uninformative responses (e.g. "I don't know" or "I would rather not answer").
Phenotype derived estimates such as prevalence and associations between variables were calculated using python. Libraries such as numpy (https://docs.scipy.org/doc/numpy/user/) and scipy (https://docs.scipy.org/doc/) were used for descriptive statistics and statsmodels (http://conference.scipy.org/proceedings/scipy2010/pdfs/seabold.pdf) was used to build logistic regression models to assess correlates of snoring and calculate odds ratios. Snoring prevalence stratified plots (e.g. Figure 1 ) were performed using seaborn v0.9.0. Confidence intervals were calculated using a bootstrapping procedure generating 1000 pseudo-replicates of the data.
Genetic association analyses and quality control.
Discovery GWAS. Analyses were performed for both sex stratified and full sample using the BOLT-LMM software tool. We used a strict quality control (QC) procedure corresponding to minor allele frequency (MAF>=0.005) and imputation quality (>=0.60).
Sensitivity analyses. Given the strong correlation between snoring and BMI, we carried out GWAS for snoring using BMI as a covariate (snoring adj. BMI) with BOLT-LMM software with a quality control corresponding to minor allele frequency (MAF>=0.005) and imputation quality (>=0.60).
Post-GWAS Annotation and Functional Mapping.
SNP annotation was conducted using the FUMA platform. Risk loci are defined as up to 250 kb based on the most right and left SNPs from each LD block. Gene based tests were performed using Multimarker Analysis of GenoMic Annotation (MAGMA) as implemented on the FUMA platform, which provides aggregate association p-values based on all variants located within a gene and its regulatory region. We used the GWAS summary statistics to conduct a MAGMA 68 analysis in the FUMA 13 platform (https://fuma.ctglab.nl/). This analysis includes a gene-based test to detect significant SNPs associated with snoring. The prioritised genes based on positional and eQTL mapping were further used to perform gene-set enrichment analysis against the traits available in the GWAS catalog.
Furthermore, we used FUMA to perform tissue enrichment analysis, based on data from the Genotype-Tissue Expression (GTEx) project (https://gtexportal.org/home/documentationPage).
Genetic correlation analyses.
We performed genetic correlation analyses to estimate genetic correlations between the discovery, sensitivity and sex-stratified snoring GWAS summary statistics using LD score regression as implemented in the Complex Trait Genomics Virtual Lab (CTG-VL, http://genoma.io). Further, in order to uncover genetically correlated traits with snoring, genetic correlation analyses using LD Score Regression (LDSC) were performed on the platforms CTG-VL and LDHub (http://ldsc.broadinstitute.org/ldhub/), which aggregate summary statistics for GWAS on hundreds of traits.
Mendelian randomisation
Mendelian randomisation (MR) is a method in which genetic variants (e.g. single nucleotide polymorphisms, SNPs) are used as instrumental variables to determine causal relationships between traits, environmental exposures, biomarkers, or disease outcomes 69 ; to satisfy the conditions for MR, it is not required to identify the actual causal variant because a marker in Linkage Disequilibrium (LD) with the causal variant can serve as a proxy instrument 70 . Moreover, in order to draw conclusions in regard with casual effects, three relevant assumptions must be taken into consideration: (I) genetic variants must be associated with the exposure of interest; (II) genetic variants must not be confounded; (III) genetic variants must be independent of the outcome through other mechanisms. 71 We used Generalised Summary-data-based Mendelian Randomisation (GSMR) 70 , an approach that leverages the usage of multiple independent variables (SNPs) strongly associated with the outcome to overcome these assumptions, as implemented in the CTG -VL (http://genoma.io). We used GSMR to assess causal relationships between snoring and: BMI, whole body fat mass and pulse rate using our results and existing summary statistics for these traits. To avoid possible confounding from sample overlap, we performed GSMR using the summary statistics derived from sex-stratified GWAS. For example, the female snoring GWAS results were used as exposure while the male pulse rate GWAS results were used for the outcome.
Target sample and polygenic scoring
In order to quantify for the cumulative genetic associations for snoring, we calculated PGS using a clumping + thresholding approach. Study description and sample characteristics of the Australian Genetics of Depression study is available elsewhere. 72 Genotyping was conducted using the Illumina Infinium Global Screening Array platform and genotype imputation using the Haplotype Reference standard quality control procedures. Briefly, for PGS estimation, we excluded indel, strand ambiguous-and low (R2<0.6) imputation quality-variants. The most significant SNPs were selected using a conservative clumping procedure (PLINK1.9 74 ; p1=1, p2=1, r2=0.1, kb=10000) to correct for inflation arising from linkage disequilibrium (LD). Eight PGS were calculated using different p- LD score regression derived SNP based heritability results. Estimates were transformed to the liability scale assuming equal population and sample prevalences. λGC is the genomic inflation factor and intercept is the LD score regression intercept
